Kåre Schultz, Teva CEO (Christopher Goodney/Bloomberg via Getty Images)
Teva reaches $523M agreement with New York in latest opioid-related settlement
Teva has been working on making headway with its planned national settlement over its role in the US opioid epidemic. And it has one less state to be focused on.
Teva execs confirmed that a settlement was reached in New York, echoing an announcement from New York Attorney General Letitia James earlier this week. The AG confirmed that the state gets more than half a billion dollars from the generics giant, ending the state’s litigation against opioid manufacturers and distributors.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters